News

KCTV shares the story of one Saint Luke's heart transplant recipient who shares a special bond with his heart donor's family.

During Heart Month, we are talking about the risks of undiagnosed heart failure and treatment options for those with heart failure.

FOX4 talked to Ted Perez and his heart transplant surgeon, Dr. Russ Davis, about the lifelong Chiefs fan's incredible story.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

The heart transplant team at Saint Luke’s Mid America Heart Institute recently performed its 1,000th transplant, reaching a prestigious milestone less than 25 hospitals in the nation have managed to accomplish.

A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.

Saint Luke’s program becomes the 23rd institution in the U.S. to perform 1,000 heart transplants.

The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Semaglutide, the active ingredient on weight loss drugs Wegovy and Ozempic, shows evidence that the drug may also help reduce the risks of heart disease.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.